Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 984,648 | 779,709 | 594,001 | 279,834 | 189,718 |
| Marketable Securities | 960,723 | 359,987 | 282,738 | 130,871 | 583,658 |
| Receivables | 181,621 | 158,554 | 160,822 | 155,614 | 110,455 |
| Inventories | 79,647 | 23,194 | 30,577 | 21,808 | 15,856 |
| TOTAL | $2,273,948 | $1,365,531 | $1,218,629 | $693,785 | $954,368 |
| Non-Current Assets | |||||
| PPE Net | 55,371 | 60,970 | 87,089 | 72,590 | 52,585 |
| Intangibles | 471,094 | 201,135 | 461,838 | 788,232 | 807,182 |
| Other Non-Current Assets | 98,354 | 77,388 | 128,142 | 151,012 | 123,921 |
| TOTAL | $624,819 | $339,493 | $677,069 | $1,011,834 | $983,688 |
| Total Assets | $2,898,767 | $1,705,024 | $1,895,698 | $1,705,619 | $1,938,056 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 569,631 | 257,821 | 194,314 | 72,149 | 208,831 |
| Accounts payable and accrued liabilities | 381,272 | 304,292 | 391,983 | 320,366 | 288,784 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,460 |
| TOTAL | $968,427 | $580,981 | $603,100 | $406,236 | $509,348 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,025,366 | 2,109,367 | 1,903,996 | 1,257,459 | 956,588 |
| Deferred Revenues | 2,040 | 5,505 | 801 | 1,351 | N/A |
| Other Non-Current Liabilities | 107,287 | 97,173 | 134,068 | 267,501 | 313,519 |
| TOTAL | $2,135,653 | $2,222,114 | $2,111,153 | $1,646,469 | $1,427,270 |
| Total Liabilities | $3,104,080 | $2,803,095 | $2,714,253 | $2,052,705 | $1,936,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,775 | 78,869 | 76,608 | 73,815 | 71,362 |
| Common Shares | 80 | 77 | 75 | 72 | 71 |
| Retained earnings | -2,964,229 | -3,646,873 | -3,283,578 | -2,656,974 | -2,097,957 |
| Other shareholders' equity | 10,501 | -25,886 | -1,285 | 4,796 | -24,282 |
| TOTAL | $-205,313 | $-1,098,071 | $-818,555 | $-347,086 | $1,438 |
| Total Liabilities And Equity | $2,898,767 | $1,705,024 | $1,895,698 | $1,705,619 | $1,938,056 |